HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Clemente-based USGI Medical Inc. has raised more than $19.5 million from equity and debt investors.
Irvine-based Allergan Inc. has set a March 10 special meeting to get shareholder approval of its acquisition by Actavis PLC in a cash-and-stock deal currently valued at about $70 billion.
Fullerton-based Marshall B. Ketchum University paid $10.3 million for an 88,000 square foot building on La Palma Avenue in Anaheim and will move its University Eye Center there, the school said.
Santa Ana College and Cypress College were named to a list of 15 community colleges statewide that can offer four-year college degrees, according to the California Community Colleges chancellor’s office.
HEALTHCARE: 2nd edition of concept at Jamboree Center
St. Joseph Hoag Health has laid another building block for the integrated regional care delivery it is establishing in Orange County.
Ontario-based Prime Health Services said it donated La Palma Intercommunity Hospital to the Prime Healthcare Foundation.
UC Irvine Medical Center Chief Executive Terry Belmont said he plans to retire from his post on June 30.
U. of Oregon Partnership Helps Teach Engineers
Irvine-based Edwards Lifesciences Corp., maker of replacement heart valves and other cardiovascular devices, is working with the Oregon Health & Science University in Portland, Ore., on a technical training program.
Latham & Watkins Partner Finished Boston Just in Time for Allergan Saga
Cary Hyden used to think a marathon covered 26 miles, 270 yards.
Ontario-based Prime Health Services said today that it donated La Palma Intercommunity Hospital to the Prime Healthcare Foundation.
UC Irvine Medical Center Chief Executive Terry Belmont said today that plans to retire from the post on June 30.
San Juan Capistrano-based Allegro Opthalmics LLC said today that it raised $20 million from South Hanmi Pharmaceutical in South Korea.
Newport Beach-based CureDuchenne Ventures LLC said today that it invested $1 million in Capricor Therapeutics Inc. to fund research for treating heart disease associated with Duchenne muscular dystrophy.
Irvine-based Allergan Inc. and Dublin-based Actavis Plc said the U.S. Federal Trade Commission granted early termination of a federal regulatory waiting period and set a ‘shareholder-of-record’ date for the $68 billion acquisition of Allergan by Actavis.